Utah Medical Products Soft Earnings Dont Show The Whole Picture
| CEOS Stock | USD 0.03 0 3.70% |
Slightly above 56% of all CeCors' private investors are looking to take a long position. The analysis of overall sentiment of trading CeCors Inc pink sheet suggests that some investors are interested at this time. CeCors' investing sentiment can be driven by a variety of factors including economic data, CeCors' earnings reports, geopolitical events, and overall market trends.
CeCors pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CeCors daily returns and investor perception about the current price of CeCors Inc as well as its diversification or hedging effects on your existing portfolios.
CeCors |
Shareholders appeared unconcerned with Utah Medical Products, Inc.s lackluster earnings report last...
Read at finance.yahoo.com
 |
CeCors Fundamental Analysis
We analyze CeCors' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeCors using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeCors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
CeCors is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
CeCors Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CeCors pink sheet to make a market-neutral strategy. Peer analysis of CeCors could also be used in its relative valuation, which is a method of valuing CeCors by comparing valuation metrics with similar companies.
Peers
CeCors Related Equities
| BNGO | Bionano Genomics | 8.33 | ||||
| POAI | Predictive Oncology | 3.85 | ||||
| LUCY | Innovative Eyewear | 2.46 | ||||
| AVGR | Avinger | 1.20 | ||||
| UTMD | Utah Medical | 0.15 | ||||
| GCTK | GlucoTrack | 4.00 | ||||
| NXGL | Nexgel | 4.22 | ||||
| STSS | Sharps Technology | 5.29 | ||||
| ZJYL | JIN MEDICAL | 7.14 |
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.